-
1
-
-
35448993443
-
A systematic review of populationbased studies of infective endocarditis
-
Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, Wilson WR, Baddour LM. 2007. A systematic review of populationbased studies of infective endocarditis. Chest 132:1025-1035.
-
(2007)
Chest
, vol.132
, pp. 1025-1035
-
-
Tleyjeh, I.M.1
Abdel-Latif, A.2
Rahbi, H.3
Scott, C.G.4
Bailey, K.R.5
Steckelberg, J.M.6
Wilson, W.R.7
Baddour, L.M.8
-
2
-
-
77951743891
-
Epidemiological trends of infective endocarditis: A population-based study in Olmsted County, Minnesota
-
Correa de Sa DD, Tleyjeh IM, Anavekar NS, Schultz JC, Thomas JM, Lahr BD, Bachuwar A, Pazdernik M, Steckelberg JM, Wilson WR, Baddour LM. 2010. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin. Proc. 85:422-426.
-
(2010)
Mayo Clin. Proc.
, vol.85
, pp. 422-426
-
-
Correa De Sa, D.D.1
Tleyjeh, I.M.2
Anavekar, N.S.3
Schultz, J.C.4
Thomas, J.M.5
Lahr, B.D.6
Bachuwar, A.7
Pazdernik, M.8
Steckelberg, J.M.9
Wilson, W.R.10
Baddour, L.M.11
-
3
-
-
79960483114
-
Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: Before and after study
-
Thornhill MH, Dayer MJ, Forde JM, Corey GR, Chu VH, Couper DJ, Lockhart PB. 2011. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ 3:342-348.
-
(2011)
BMJ
, vol.3
, pp. 342-348
-
-
Thornhill, M.H.1
Dayer, M.J.2
Forde, J.M.3
Corey, G.R.4
Chu, V.H.5
Couper, D.J.6
Lockhart, P.B.7
-
4
-
-
84859760122
-
Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: Three successive population- based surveys
-
on behalf of the Study Group AEPEI.
-
Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B, on behalf of the Study Group AEPEI. 2012. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population- based surveys. J. Am. Coll. Cardiol. 59:1968-1976.
-
(2012)
J. Am. Coll. Cardiol.
, vol.59
, pp. 1968-1976
-
-
Duval, X.1
Delahaye, F.2
Alla, F.3
Tattevin, P.4
Obadia, J.F.5
Le Moing, V.6
Doco-Lecompte, T.7
Celard, M.8
Poyart, C.9
Strady, C.10
Chirouze, C.11
Bes, M.12
Cambau, E.13
Iung, B.14
Selton-Suty, C.15
Hoen, B.16
-
5
-
-
84856581006
-
The perpetual challenge of infectious diseases
-
Fauci AS, Morens DM. 2012. The perpetual challenge of infectious diseases. N. Engl. J. Med. 366:454-461.
-
(2012)
N. Engl. J. Med.
, vol.366
, pp. 454-461
-
-
Fauci, A.S.1
Morens, D.M.2
-
6
-
-
59449088862
-
Antibiotic resistant bugs in the 21st century. A clinical super challenge
-
Arias CA, Murray BE. 2009. Antibiotic resistant bugs in the 21st century. A clinical super challenge. N. Engl. J. Med. 360:439-443.
-
(2009)
N. Engl. J. Med.
, vol.360
, pp. 439-443
-
-
Arias, C.A.1
Murray, B.E.2
-
7
-
-
84862072789
-
-
US Food and Drug Administration., Washington, DC.
-
US Food and Drug Administration. 2006. Efficacy supplement approvals in 2006. US Food and Drug Administration, Washington, DC. http://www.fda.gov/drugs/ developmentapprovalprocess/howdrugsar edevelopedandapproved/ drugandbiologicapprovalreports/efficacysu pplementapprovals/ucm081895.htm.
-
(2006)
Efficacy supplement approvals in 2006
-
-
-
8
-
-
33747365321
-
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
-
for the S. aureus Endocarditis and Bacteremia Study Group.
-
Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, for the S. aureus Endocarditis and Bacteremia Study Group. 2006. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355: 353-365.
-
(2006)
N. Engl. J. Med.
, vol.355
, pp. 353-365
-
-
Fowler, V.G.1
Boucher, H.W.2
Corey, G.R.3
Abrutyn, E.4
Karchmer, A.W.5
Rupp, M.E.6
Levine, D.P.7
Chambers, H.F.8
Tally, F.P.9
Vigliani, G.A.10
Cabell, C.H.11
Link, A.S.12
Demeyer, I.13
Filler, S.G.14
Zervos, M.15
Cook, P.16
Parsonnet, J.17
Bernstein, J.M.18
Price, C.S.19
Forrest, G.N.20
Fätkenheuer, G.21
Gareca, M.22
Rehm, S.J.23
Brodt, H.R.24
Tice, A.25
Cosgrove, S.E.26
more..
-
9
-
-
33644694712
-
Daptomycin for the treatment of Gram positive bacteremia and infective endocarditis: A retrospective case series of 31 patients
-
Segreti JA, Crank CW, Finney MS. 2006. Daptomycin for the treatment of Gram positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy 26:347-352.
-
(2006)
Pharmacotherapy
, vol.26
, pp. 347-352
-
-
Segreti, J.A.1
Crank, C.W.2
Finney, M.S.3
-
11
-
-
78650589853
-
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study
-
Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, Segreti J. 2010. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: a retrospective, multicenter, cohort study. Clin. Ther. 32:1713-1719.
-
(2010)
Clin. Ther.
, vol.32
, pp. 1713-1719
-
-
Crank, C.W.1
Scheetz, M.H.2
Brielmaier, B.3
Rose, W.E.4
Patel, G.P.5
Ritchie, D.J.6
Segreti, J.7
-
12
-
-
80053345054
-
Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci
-
Cervera C, Castañeda X, Pericas JM, del Río A, García de la Mariac C, Mestresd C, Falcese C, Marcoc F, Moreno A, Miró JM. 2011. Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci. J. Antimicrob. Agents 38:365-370.
-
(2011)
J. Antimicrob. Agents
, vol.38
, pp. 365-370
-
-
Cervera, C.1
Castañeda, X.2
Pericas, J.M.3
Del Río, A.4
De La Mariacgarcía, C.5
Mestresd, C.6
Falcese, C.7
Marcoc, F.8
Moreno, A.9
Miró, J.M.10
-
13
-
-
84875236583
-
Daptomycin for the treatment of infective endocarditis: Results from a European registry
-
Dohmen PM, Guleri A, Capone A, Utili R, Seaton RA, González- Ramallo VJ, Pathan R, Heep M, Chaves RL. 2013. Daptomycin for the treatment of infective endocarditis: results from a European registry. J. Antimicrob. Chemother. 68:936-942.
-
(2013)
J. Antimicrob. Chemother.
, vol.68
, pp. 936-942
-
-
Dohmen, P.M.1
Guleri, A.2
Capone, A.3
Utili, R.4
Seaton, R.A.5
González- Ramallo, V.J.6
Pathan, R.7
Heep, M.8
Chaves, R.L.9
-
14
-
-
34748897916
-
Daptomycin in the treatment of patients with infective endocarditis: Experience from a registry
-
doi:10.1016/j.amjmed.2007.07.011
-
Levine DP, Lamp KC. 2007. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry. Am. J. Med. 120:S28- S33. doi:10.1016/j.amjmed.2007.07.011.
-
(2007)
Am. J. Med.
, vol.120
-
-
Levine, D.P.1
Lamp, K.C.2
-
16
-
-
84882273207
-
Treatment of Gram positive left-sided infective endocarditis with daptomycin
-
Epub ahead of print. doi:10.1007/s10156-012-0546-9
-
Kaya S, Yilmaz G, Kalkan A, Ertunc B, Koksal I. 2013. Treatment of Gram positive left-sided infective endocarditis with daptomycin. J. Infect. Chemother. [Epub ahead of print.] doi:10.1007/s10156-012-0546-9.
-
(2013)
J. Infect. Chemother.
-
-
Kaya, S.1
Yilmaz, G.2
Kalkan, A.3
Ertunc, B.4
Koksal, I.5
-
17
-
-
62349089236
-
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study
-
and International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators.
-
Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Wood CW, Cabell CH, and International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. 2009. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch. Intern. Med. 169:463-473.
-
(2009)
Arch. Intern. Med.
, vol.169
, pp. 463-473
-
-
Murdoch, D.R.1
Corey, G.R.2
Hoen, B.3
Miró, J.M.4
Fowler, V.G.5
Bayer, A.S.6
Karchmer, A.W.7
Olaison, L.8
Pappas, P.A.9
Moreillon, P.10
Chambers, S.T.11
Chu, V.H.12
Falcó, V.13
Holland, D.J.14
Jones, P.15
Klein, J.L.16
Raymond, N.J.17
Read, K.M.18
Tripodi, M.F.19
Utili, R.20
Wang, A.21
Wood, C.W.22
Cabell, C.H.23
more..
-
18
-
-
0033796633
-
Proposed modification to the Duke criteria for the diagnosis of infective endocarditis
-
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR. 2000. Proposed modification to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis. 30:633-638.
-
(2000)
Clin. Infect. Dis.
, vol.30
, pp. 633-638
-
-
Li, J.S.1
Sexton, D.J.2
Mick, N.3
Nettles, R.4
Fowler, V.G.5
Ryan, T.6
Bashore, T.7
Corey, G.R.8
-
19
-
-
25844530748
-
Infective endocarditis. Diagnosis, antimicrobial therapy, and management of complications. A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association
-
doi:10.1161/CIRCULATIONAHA.105.165564
-
Baddour LM, Wilson WR, Bayer AS, Fowler VG, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA. 2005. Infective endocarditis. Diagnosis, antimicrobial therapy, and management of complications. A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association. Circulation 111:e394-e434. doi:10.1161/CIRCULATIONAHA.105.165564.
-
(2005)
Circulation
, vol.111
-
-
Baddour, L.M.1
Wilson, W.R.2
Bayer, A.S.3
Fowler, V.G.4
Bolger, A.F.5
Levison, M.E.6
Ferrieri, P.7
Gerber, M.A.8
Tani, L.Y.9
Gewitz, M.H.10
Tong, D.C.11
Steckelberg, J.M.12
Baltimore, R.S.13
Shulman, S.T.14
Burns, J.C.15
Falace, D.A.16
Newburger, J.W.17
Pallasch, T.J.18
Takahashi, M.19
Taubert, K.A.20
more..
-
20
-
-
0036080323
-
Progress toward a global understanding of infective endocarditis: Early lessons from the International Collaboration on Endocarditis investigation
-
Cabell CH, Abrutyn E. 2002. Progress toward a global understanding of infective endocarditis: early lessons from the International Collaboration on Endocarditis investigation. Infect. Dis. Clin. North Am. 16:255-272.
-
(2002)
Infect. Dis. Clin. North Am.
, vol.16
, pp. 255-272
-
-
Cabell, C.H.1
Abrutyn, E.2
-
21
-
-
33947725644
-
International collaboration on endocarditis- prospective cohort study investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis
-
for the International Collaboration on Endocarditis-Prospective Cohort Study Investigators.
-
Wang A, Athan E, Pappas PA, Fowler VG, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Braun Jones S, Casabé J, Morris A, Corey GR, Cabell CH, for the International Collaboration on Endocarditis-Prospective Cohort Study Investigators. 2007. International Collaboration on Endocarditis- Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 297:1354- 1361.
-
(2007)
JAMA
, vol.297
, pp. 1354-1361
-
-
Wang, A.1
Athan, E.2
Pappas, P.A.3
Fowler, V.G.4
Olaison, L.5
Paré, C.6
Almirante, B.7
Muñoz, P.8
Rizzi, M.9
Naber, C.10
Logar, M.11
Tattevin, P.12
Iarussi, D.L.13
Selton-Suty, C.14
Braun Jones, S.15
Casabé, J.16
Morris, A.17
Corey, G.R.18
Cabell, C.H.19
-
22
-
-
0028224425
-
New criteria for diagnosis of infective endocarditis
-
Durack DT, Lukes AS, Bright DK. 1994. New criteria for diagnosis of infective endocarditis. Am. J. Med. 96:200-209.
-
(1994)
Am. J. Med.
, vol.96
, pp. 200-209
-
-
Durack, D.T.1
Lukes, A.S.2
Bright, D.K.3
-
23
-
-
34248401048
-
Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria
-
Mortin LI, Li T, Van Praagh AD, Zhang S, Zhang XX, Alder JD. 2007. Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria. Antimicrob. Agents Chemother. 51: 1787-1794.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 1787-1794
-
-
Mortin, L.I.1
Li, T.2
Van Praagh, A.D.3
Zhang, S.4
Zhang, X.X.5
Alder, J.D.6
-
24
-
-
44449115576
-
Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus
-
Cotroneo N, Harris R, Perlmutter N, Beveridge T, Silverman JA. 2008. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus. Antimicrob. Agents Chemother. 52:2223-2225.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 2223-2225
-
-
Cotroneo, N.1
Harris, R.2
Perlmutter, N.3
Beveridge, T.4
Silverman, J.A.5
-
25
-
-
34249906193
-
Counterpoint: Vancomycin and Staphylococcus aureus. An antibiotic enters obsolescence
-
Deresinski S. 2007. Counterpoint: vancomycin and Staphylococcus aureus. An antibiotic enters obsolescence. Clin. Infect. Dis. 44:1543-1548.
-
(2007)
Clin. Infect. Dis.
, vol.44
, pp. 1543-1548
-
-
Deresinski, S.1
-
26
-
-
33646741453
-
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus
-
Patel JB, Jevitt LA, Hageman J, McDonald LC, Tenover FC. 2006. An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clin. Infect. Dis. 42:1652-1653.
-
(2006)
Clin. Infect. Dis.
, vol.42
, pp. 1652-1653
-
-
Patel, J.B.1
Jevitt, L.A.2
Hageman, J.3
McDonald, L.C.4
Tenover, F.C.5
-
27
-
-
33644655658
-
Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin- intermediate Staphylococcus aureus
-
Cui L, Tominaga E, Neoh HM, Hiramatsu K. 2006. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin- intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50:1079-1082.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 1079-1082
-
-
Cui, L.1
Tominaga, E.2
Neoh, H.M.3
Hiramatsu, K.4
-
28
-
-
33645760459
-
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin
-
Sakoulas G, Alder J, Thauvin-Eliopoulos C, Moellering RC, Eliopoulos GM. 2006. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob. Agents Chemother. 50:1581-1585.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 1581-1585
-
-
Sakoulas, G.1
Alder, J.2
Thauvin-Eliopoulos, C.3
Moellering, R.C.4
Eliopoulos, G.M.5
-
29
-
-
79957597382
-
High-dose daptomycin for treatment of complicated Gram-positive infections: A large, multicenter, retrospective study
-
Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ. 2011. High-dose daptomycin for treatment of complicated Gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy 31:527-536.
-
(2011)
Pharmacotherapy
, vol.31
, pp. 527-536
-
-
Kullar, R.1
Davis, S.L.2
Levine, D.P.3
Zhao, J.J.4
Crank, C.W.5
Segreti, J.6
Sakoulas, G.7
Cosgrove, S.E.8
Rybak, M.J.9
|